Skip to content

Implementation of Routine Walking Speed Measurements in Older Veterans

Walking Speed as a Vital Sign: Enhancing Function in Older Veterans

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07513805
Enrollment
10500
Registered
2026-04-07
Start date
2027-04-01
Completion date
2030-06-30
Last updated
2026-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Fall Risk, Mobility Limitation

Keywords

Screening, Preventative Care, Implementation Science, RE-AIM, PRISM

Brief summary

Walking speed is a powerful predictor of mortality and adverse health consequences (e.g. fall or hospitalization) in older adults. Knowledge of individuals' walking speed can provide unique insight into current physical function and need for healthcare services. Furthermore, walking speed is a modifiable risk factor such that early recognition of physical function decline allows for appropriate and timely intervention prior to the occurrence of adverse health events. Therefore, this proposal seeks to implement routine measures of walking speed into VHA primary care as a 'vital sign' to routinely monitor Veteran physical function and help guide provider referrals.

Detailed description

Background: Walking speed is a vital sign that can predict mortality and adverse health outcomes in older adults. However, it is not routinely assessed in outpatient primary care clinics, potentially leading to missed opportunities for timely intervention and rehabilitative care. Current literature identifies walking speed as a sensitive measure of overall health and functional status, with a walking speed of \<0.6 m/s indicating increased risk of adverse events and reduced independence. Consequently, knowledge of individuals' walking speed can provide unique insight into current physical function and need for healthcare services. Importantly, walking speed is also a modifiable risk factor and is sensitive to change in multiple populations with varying medical conditions, making it an ideal measure for longitudinal monitoring of physical function. The investigators' preliminary work implementing walking speed measurement into outpatient geriatric clinical care, along with recent literature, demonstrates that routine walking speed assessments are feasible, quick, and safe. Significance: Current VHA standard of care within primary care clinics relies on subjective information to evaluate a Veteran's physical function, which can be unreliable and inaccurate. Implementation of walking speed will introduce an objective measure that can accurately assess how a Veteran's physical function changes over time, thus helping providers identify whether referrals to rehabilitation services are needed. Innovation and Impact: This proposal is innovative as it will be one of the first studies to assess the implementation and effect of walking speed across multiple primary care clinics. Additionally, examination of contextual factors influencing the implementation and effect of walking speed is innovative and will lead to adaptations that facilitate future widespread implementation. Methodology: Pragmatic hybrid type 2 effectiveness-implementation study using a stepped-wedge cluster randomized trial design to evaluate and improve walking speed implementation and assess its effectiveness across VHA PACT clinics.

Interventions

OTHERUsual Care

During the Usual Care phase, participating clinics will continue with usual care with the addition that walking speed will be measured and recorded. Veterans and providers will be blinded to walking speed measurement so as to not influence care.

OTHERFASTER

During the FASTER phase, walking speed will be measured during clinic visits, recorded in the medical record, and used by providers to guide care. An Action Toolkit will be provided with resources for providers to support informed care decisions based on Veterans' walking speeds.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Masking description

Those analyzing the quantitative data will be blinded to study phase.

Intervention model description

The FASTER intervention includes three stages. First, the Veteran is instructed to walk over a 6-meter course (4-meter timed course with 1-meter acceleration and deceleration zones) with an emphasis on walking at their usual pace. While the Veteran walks this course, a stopwatch is used to measure walking speed. Second, the walking speed is input into the medical record along with any assistive device used during measurement. Third, providers use the walking speed information to help guide care and potential referrals.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Site Inclusion Criteria: * VHA primary care clinics VHA Personnel Inclusion Criteria: * Providers working in a VHA primary care clinic where FASTER is implemented * Nursing staff working in a VHA primary care clinic where FASTER is implemented Veteran Inclusion Criteria: * Veterans 60 years and older receiving care in a VHA primary care clinic where FASTER is implemented

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Walking SpeedChange in walking speed before exposure and change in walking speed after exposure to FASTER intervention (up to 12 months).Time to complete 4-meter walk at usual speed converted to meters per second. Higher speed indicates better function.

Secondary

MeasureTime frameDescription
Adverse Events (Injurious Falls)Start of usual care to end of implementation (anticipated 24 months).Falls that result in a medical visit
Adverse Events (Emergency Department Visits and Hospitalizations)Start of usual care to end of implementation (anticipated 24 months).Emergency department visits and hospitalizations

Countries

United States

Contacts

CONTACTJennifer E Stevens-Lapsley, PhD
Jennifer.Stevens-Lapsley@va.gov(303) 949-9304
CONTACTJoyce A Middleton
joyce.middleton@va.gov(303) 908-8935
PRINCIPAL_INVESTIGATORJennifer E. Stevens-Lapsley, PhD

Rocky Mountain Regional VA Medical Center, Aurora, CO

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026